Revance Therapeutics stock soars 16% as Teoxane proposes $360m deal

Teoxane S.A., a global leader in the medical aesthetics sector based in Geneva, Switzerland, has made a bold move to acquire Revance Therapeutics, Inc. (Nasdaq: ... Read More